To investigate the role of TLK expression in modulating cell death following PARP inhibition or deficiency in BRCA1-deficient cancers, we categorized breast cancer cell lines from the CCLE based on the presence or absence of BRCA1 mutations. This evidence concerns the gene BRCA1 and breast cancer.